IRIDEX (US:IRIX) Globenewswireยท2025-10-28 20:05Core Viewpoint - Iridex Corporation is set to release its financial results for Q3 2025 on November 11, 2025, along with a business update [1]. Company Overview - Iridex Corporation is a leader in developing, manufacturing, and marketing laser-based medical systems and devices for the ophthalmology market [3]. - The company specializes in innovative technologies, particularly its proprietary MicroPulse technology, which offers safe and effective treatments for eye conditions [3]. - Iridex's products are utilized for treating glaucoma, diabetic macular edema (DME), and other retinal diseases, and are distributed in over 100 countries [3]. Conference Call Details - A conference call will be held on November 11, 2025, at 2:00 p.m. PT / 5:00 p.m. ET for investors to discuss the financial results [2]. - Investors can join the call by dialing specific numbers and using a provided Conference ID [2].